Table 1 Clinical and general characteristics of study population at baseline
From: Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors
Group | Age | Sex | Comorbidities | Smoking | Site | Functioning | Grade | Stage (TNM) |
|---|---|---|---|---|---|---|---|---|
Patients | ||||||||
 #1 | 60 | F | No | No | Pancreas | No | G1 | Localized (cT1N0M0) |
 #2 | 59 | F | No | No | Pancreas | Yes (insulinoma) | G1/G2 | Metastatic (pT2pN0M1a R0) |
 #3 | 45 | M | Autoimmune thyroiditis, hypothyroidism | No | Pancreas | Yes (insulinoma) | G1 | Localized (pT1pN0) |
 #4 | 80 | M | IFG, Hypertension, Dyslipidemia, MI | No | Ileum | No | G2 | Metastatic |
 #5 | 61 | F | DM, Hypertension, Dyslipidemia | No | Ileum | No | G2 | Metastatic |
 #6 | 61 | M | DM, Glaucoma, Cryptogenic Organizing Pneumonia, JAK2 +  | No | Pancreas/Duodenum | No | G2 | Metastatic |
 #7 | 57 | M | No | No | Pancreas | Yes (insulinoma) | G2 | Metastatic |
 #8 | 57 | M | IFG, hypertension, dyslipidemia, stroke | Yes | Ileum | No | G2 | Metastatic |
 #9 | 59 | M | Hypertension, Thyroid nodule | No | Ileum | No | G1 | Metastatic |
 #10 | 70 | M | DM, Hypertension, Dyslipidemia, COPD, Hypothyroidism, MGUS | Yes | Pancreas | No | G1 | Localized |
Controls | ||||||||
 #1 | 66 | M | Hypertension, multinodular goiter | No | – | – | – | – |
 #2 | 44 | F | Multinodular goiter | No | – | – | – | – |
 #3 | 46 | M | IFG, hypertension, thyroid nodule | No | – | – | – | – |
 #4 | 69 | F | Multinodular goiter | No | – | – | – | – |
 #5 | 65 | F | Hypertension | No | – | – | – | – |